25/01/2022 - General information
A study by CiSAL and CIBERESP shows that, once they have returned to work, they work at a lower rate than those who have not suffered from the disease. Men and women who had no sick leave or who were on sick leave for other illnesses were at least 9% more likely to continue working compared to workers who took cancer-related sick leave, according to this study carried out in Catalonia and published in 'Scientific Reports'. Not being able to work when you can and want to leads to a loss of self-esteem and social relationships, which can make recovering from cancer psychologically difficult", explains Fernando G. Benavides, the coordinator of the study.
21/01/2022 - Covid-19
12% of patients admitted for COVID-19 who also suffer heart damage need to be readmitted or die within the first year after recovering from the disease. In contrast, this occurs in only 1% of those who do not suffer heart damage during the SARS-CoV-2 infection, according to a study published in the Journal of Clinical Medicine. These people have a baseline situation that is aggravated by previous pathologies such as high blood pressure, chronic renal failure and episodes of heart failure. The authors of the study recommend routine screening for heart damage markers in the blood of patients admitted for COVID-19 to be able to carefully monitor these problems in the long term. Patients who suffer heart damage during a COVID-19 infection are more likely to need to be readmitted to hospital or to die than those who survive the disease without suffering this. This has been revealed by a study led by researchers from Hospital del Mar, the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the CIBER in Cardiovascular Diseases (CIBERCV), which has been published in the Journal of Clinical Medicine.
Més informació "Cardiac damage in COVID-19 patients is an indicator of poor long-term prognosis"
20/12/2021 - General information
The urgent need to find treatments for a large number of degenerative diseases has led a group of experts to develop a guide designed to accelerate new drug discoveries for neurological and psychiatric diseases. Project leads are Dr. Silvia Zaragoza Domingo, consultant and founder of Neuropsynchro, Barcelona, serving as coordinator collaborating with Drs. Jordi Alonso and Montserrat Ferrer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) and CIBERESP, and Dr. Manuel de Gracia, Facultat de Psicologia of Universitat de Girona (UdG). This guide was presented during the 34th Congress of the European Clinical Neurosychopharmacological College (ECNP) in Lisbon on 2-5 October and has been the group's priority project since it was established in 2018.
18/11/2021 - Press release
A study by researchers from Hospital del Mar, the Hospital del Mar Medical Research Institute and Hospital Son Espases, shows that the combination of a new antibiotic, ceftazidime/avibactam, with other antibiotics, can treat infections caused by variants of Pseudonomas aeruginosa that are resistant to all existing treatments. The study, published in Microbiology Spectrum, involved an in vitro analysis of the efficacy of the different treatments and their combinations to determine their effectiveness against variants of this bacterium, which is resistant to all existing drugs. Resistance to antibiotics has been identified by the World Health Organisation as one of the main threats to global health. Infection with Pseudomonas aeruginosa can cause pneumonia, heart problems and sepsis, especially in immunocompromised people
26/10/2021 - Press release
The risk of death from any cause increases by 30% for each 10 beat per minute increase above 70 beats per minute The study, led by researchers at the Hospital del Mar Medical Research Institute, analysed data from more than 10,000 participants in the REGICOR study to establish the relationship between heart rate and the risk of cardiovascular disease and death It is a simple measurement indicator, which also provides information on the risk of cardiovascular disease. The work has been published in the European Journal of Preventive Cardiology
Més informació "A higher heart rate is associated with a greater risk of death"
These are obese patients with no associated diseases, referred to as metabolically healthy, who account for one in five people who undergo bariatric surgery. Their levels of cholesterol, glucose, triglycerides and fatty liver markers continue to fall five years after surgery The improvement is less than that seen in obese patients who do have metabolic problems prior to undergoing surgery and who, therefore, start from higher levels, but it demonstrates the usefulness of applying this surgical procedure to these individuals This has been demonstrated in a study by the Endocrinology and Nutrition Service at Hospital del Mar, the first in Spain, published in the journal Surgery for Obesity and Related Diseases
Més informació "Bariatric surgery improves long-term health of metabolically healthy obese patients"
21/07/2021 - Press release
Levels of omega-3 fatty acids in the blood are as good a predictor of mortality from any cause as smoking, according to a study involving the Hospital del Mar Medical Research Institute (IMIM), in collaboration with The Fatty Acid Research Institute in the United States and several universities in the United States and Canada. The study, published in The American Journal of Clinical Nutrition, used data from a long-term study group, the Framingham Offspring Cohort, which has been monitoring residents of this Massachusetts town, in the United States, since 1971. Researchers have found that omega-3 levels in blood erythrocytes (the so-called red blood cells) are very good mortality risk predictors.
Two professionals from the Laboratory will travel to the Japanese capital to support the anti-doping work that will take place during the Olympic Games, which begin on July 23. The Hospital del Mar Institute for Medical Research (IMIM) will once again be Olympic. Two of the Anti-Doping Laboratory of Catalonia professionals at IMIM will work at the Olympic Games Laboratory in Tokyo, which starts this July 23. Sergi Coll and Lídia Requena will travel to Tokyo to work there until August 10. Sergi Coll specializes in detecting anabolic steroids, and Lídia Requena specializes in detecting hormones (erythropoietin, growth hormone ...) and blood transfusions.
22/06/2021 - Press release
6.4% of the European population suffers from depression, according to a study published in The Lancet Public Health. The work was led by researchers from King's College London, the Hospital del Mar Medical Research Institute (IMIM), the Parc de Recerca Sant Joan de Déu-Institut de Recerca Sant Joan de Déu, the Institute of Biomedicine at the University of León (IBIOMED), and the CIBER on Epidemiology and Public Health (CIBERESP). This figure is higher than that estimated by the World Health Organisation (WHO), which calculated the prevalence of this pathology in the European region at 4.2%. Depression is considered to be one of the leading causes of disability around the world, increasing the risk of premature death, decreasing quality of life and being a heavy burden on health systems. In fact, it is estimated that it may affect more than 300 million people worldwide.
Més informació "More than 6% of Europeans suffer from depression"
01/06/2021 - General information
The Jury of the Àngel Prize for Occupational Medicine 2021 has awarded the Prize convened by the Catalan Association of Occupational Health to Dr. Consol Serra Pujadas, in recognition of her dedication to defending health of working people. Consol Serra is the coordinator of the University Pompeu Fabra (UPF) and Hospital del Mar Medical Research Institute (IMIM) Center for research in Occupational Health, Head of the Occupational Health Service of the PSMar and Head of Studies of the "Mateu Orfila-UPF" Occupational Medicine Teaching Unit. The award ceremony will take place on June 15, during the General Assembly of members of the Catalan Association of Occupational Health
Més informació "Consol Serra Angel Award for Occupational Medicine 2021"
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
